-
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1616)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2022 (publication date) through Feb 5, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Katoch S, Sharma V, Patial V. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios. World J Gastroenterol 2022; 28(28): 3535-3554 [PMID: 36161051 DOI: 10.3748/wjg.v28.i28.3535] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i28/3535.htm |
| Number | Citing Articles |
| 1 |
Zhenshan Zhang, Leilei Wu, Juan Li, Jiayan Chen, Qi Yu, Hui Yao, Yaping Xu, Liang Liu. Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03790-0
|
| 2 |
Vinesh Sharma, Vikram Patial. Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.991059
|
| 3 |
Ephraim E Parent, Amy M Fowler. Nuclear Receptor Imaging In Vivo—Clinical and Research Advances. Journal of the Endocrine Society 2023; 7(3) doi: 10.1210/jendso/bvac197
|